Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
Neurology·MeSH: Amyloid Neuropathies, Familial
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| NTLA-2001 | Intellia Therapeutics, Inc. (NTLA) |
Frequently asked questions
How many drugs are in development for Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy?
BioSniper tracks 1 drug in development for Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy across 1 company.
How many clinical trials target Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy?
There are 3 clinical trials targeting Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy tracked by BioSniper.
Deep-dive into Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis